Back to browse

Tat-A1E28

Peptide ID
PEPTIDE000444
Raw sequence
Tat-AP1-ELP (VPGXG)x28
Clean backbone
YGRKKRRQRRRGGGRKRLDRNGGGVPGVGVPGVGVPGVGVPGVGVPGVGVPGFGVPGFGVPGVGVPGVGVPGVGVPGGGVPGGGVPGGGVPGAGVPGVGVPGVGVPGVGVPGVGVPGVGVPGFGVPGFGVPGVGVPGVGVPGVGVPGGGVPGGGVPGGGVPGAG
Tokenized backbone
Y-G-R-K-K-R-R-Q-R-R-R-G-G-G-R-K-R-L-D-R-N-G-G-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-F-G-V-P-G-F-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-G-G-V-P-G-G-G-V-P-G-G-G-V-P-G-A-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-F-G-V-P-G-F-G-V-P-G-V-G-V-P-G-V-G-V-P-G-V-G-V-P-G-G-G-V-P-G-G-G-V-P-G-G-G-V-P-G-A-G
Sequence engineering
Tat + GGG + AP1 (RKRLDRN) + GGG + E28
Stereochemistry
L (assumed)
Modifications
Adds IL-4R targeting AP1; recombinant fusion; likely C-terminal Cys
Sequence length
164
Noncanonical residues

Experiments